| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/29/2004 | WO2004062568A2 Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent |
| 07/29/2004 | WO2004062498A1 Method for acquiring electromagnetic signals and contrast product therefor |
| 07/29/2004 | WO2004035536A3 Azo compounds for type i phototherapy |
| 07/29/2004 | WO2004028449A3 Azulene dimer-quenched, near-infrared fluorescent probes |
| 07/29/2004 | WO2004015392A3 Improved method to identify targeting molecules |
| 07/29/2004 | WO2003099783A3 Tropane compounds |
| 07/29/2004 | US20040147508 Biologically active methylene blue derivatives |
| 07/29/2004 | US20040147500 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 07/29/2004 | US20040147499 Chlorins and purpurins |
| 07/29/2004 | US20040146946 used to study oxidative stress-related disorders and diseases and drug screening treatments for Alzheimer's disease |
| 07/29/2004 | US20040146945 used to study oxidative stress-related disorders and diseases and drug screening treatments for Alzheimer's disease |
| 07/29/2004 | US20040146516 Lumen-exposed molecules and methods for targeted delivery |
| 07/29/2004 | US20040146479 Washing hands with first composition for removal of any anionic species which reduce the bactericidal efficacy of biocides, ensuring that no composition containing an anionic surfactant contacts the skin after step (1) |
| 07/29/2004 | US20040146463 Functional MRI agents for cancer imaging |
| 07/29/2004 | US20040146462 Ultrasonic visualisation of perfusion in the myocardium and other tissues is performed using novel gas-containing contrast agent preparations which promote controllable and temporary growth of the gas phase in vivo following administration |
| 07/29/2004 | US20040146461 Gastrointestinal contrast medium for abdomen includes salt of diatrizoic acid; nontoxic, oral, crystalline, low calorie beverage; side effect reduction |
| 07/29/2004 | CA2513133A1 Porphyrin derivatives |
| 07/28/2004 | EP1439860A1 Magnetic nanodispersion comprising cyclodextrines and method for the production thereof |
| 07/28/2004 | EP1439854A2 Conformationally constrained parathyroid hormone (pth) analogs |
| 07/28/2004 | EP1439819A1 Formulation of an erodible, gastic retentive oral dosage form using in vitro disintegration test data |
| 07/28/2004 | CN1515552A Near infrared fluorescence contrast agent and fluorescence imaging |
| 07/28/2004 | CN1515244A Protein-stable pharmacological active matter, its preparation and application method |
| 07/28/2004 | CN1159065C Spiral CT three-D simulation endoscope contrast medium and producing method thereof |
| 07/27/2004 | US6767711 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 07/27/2004 | US6767635 Magnetic nanoparticles having biochemical activity, method for the production thereof and their use |
| 07/27/2004 | CA2056371C Stable microbubbles suspensions injectable into living organisms |
| 07/22/2004 | WO2004061410A2 Serum biomarkers in lung cancer |
| 07/22/2004 | WO2004060053A2 Transgenic mice expressing human cd20 |
| 07/22/2004 | WO2004060052A2 Transgenic mice expressing human cd20 and/or cd16 |
| 07/22/2004 | WO2004060041A2 Kim-1 antagonists and use to modulate immune system |
| 07/22/2004 | WO2003101919A3 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
| 07/22/2004 | US20040143180 Medical devices visible under magnetic resonance imaging |
| 07/22/2004 | US20040143179 Diagnostic procedures using direct injection of gaseous hyperpolarized 129Xe and associated systems and products |
| 07/22/2004 | US20040142917 Porphyrin derivatives |
| 07/22/2004 | US20040142493 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 07/22/2004 | US20040141983 Compositions against cancer antigen LIV-1 and uses thereof |
| 07/22/2004 | US20040141974 use of the protein BCMP 7, compositions comprising the protein, including vaccines, and antibodies that are immunospecific for the protein, in the diagnosis, prophylaxis and treatment of cancer |
| 07/22/2004 | US20040141922 Ultrasound contrast agents |
| 07/22/2004 | US20040141921 Contrast agents |
| 07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
| 07/22/2004 | DE10259793A1 Image forming method for use in medical field, involves providing polarized substance to living organism, and obtaining metabolism image indicating distribution of substance using magnetic-resonance apparatus |
| 07/22/2004 | CA2512138A1 Kim-1 antagonists and use to modulate immune system |
| 07/22/2004 | CA2507882A1 Transgenic mice expressing human cd20 |
| 07/22/2004 | CA2507880A1 Transgenic mice expressing human cd20 and/or cd16 |
| 07/21/2004 | EP1438974A2 pH-sensitive liposomes based on diacyl-glycero-phosphoethanolamine and diacyl-succinyl-glycerol |
| 07/21/2004 | EP1438600A2 Optical pumping modules, polarized gas blending and dispensing systems, and automated polarized gas distribution systems |
| 07/21/2004 | EP1438599A1 Automated modular hyperpolarizers |
| 07/21/2004 | EP1438326A2 Diagnosing, treating, and preventing cancer using cables |
| 07/21/2004 | EP1438318A1 Tissue specific fluorescent chelates |
| 07/21/2004 | EP1438299A1 Bifunctional chelating agent for actinium |
| 07/21/2004 | EP1438076A1 Radiopharmaceutical agent for the treatment of early stage cancer |
| 07/21/2004 | EP1289571B1 Prochelators of radiometal labeled molecules |
| 07/21/2004 | EP1274465B1 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability |
| 07/21/2004 | CN1158528C Skin test for schizophrenia |
| 07/15/2004 | WO2004058703A2 Methods of identifying longevity modulators and therapeutic methods of use thereof |
| 07/15/2004 | WO2004058343A1 Soft filament occlusive device delivery system |
| 07/15/2004 | WO2004058310A1 Liquid embolisate |
| 07/15/2004 | WO2004058275A2 Compositions of magnetic particles covered with gem-bisphosphonate derivatives |
| 07/15/2004 | WO2004044149A3 Method for suppressing immune system response to transplanted tissue or cells |
| 07/15/2004 | WO2004031348A3 Method for convection enhanced delivery of therapeutic agents |
| 07/15/2004 | WO2004015128A3 Specific shotgun targeting and manipulation of cells and tissues associated with pathogenesis, and libraries for the same |
| 07/15/2004 | WO2004006965A3 Use of metal complexes containing perfluoroalkyl as contrast agents in magnetic resonance imaging for representing intravascular thrombi |
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040137427 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 07/15/2004 | US20040136911 Diethylenetriaminepentacetic acid chelator conjugated to polylysine and labeled with gadolinium; unfolded conformation; MRI assessment of tumor angiogenesis |
| 07/15/2004 | US20040136910 Differentiating tumors from healthy cells by placing the marker-folate conjugate in contact with excised or in vivo tissue and viewing |
| 07/15/2004 | DE10261694A1 Flüssiges Embolisat Liquid embolic |
| 07/14/2004 | EP1437144A1 Rapid in-vivo test for Transmissible Spongiform Encephalopathy in the eye |
| 07/14/2004 | EP1436624A1 A method of diagnosis and treatment and agents useful for same |
| 07/14/2004 | EP1436429A2 Targeted nucleic acid constructs and uses related thereto |
| 07/14/2004 | EP1436325A1 Microfluidized leishmania antigen and methods of making and using thereof |
| 07/14/2004 | EP1435935A2 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 07/14/2004 | EP1435908A1 Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof |
| 07/14/2004 | EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 07/14/2004 | EP1435774A1 Enhanced resolution of tumor metastasis |
| 07/14/2004 | EP0818989B1 Novel compositions of lipids and stabilizing materials |
| 07/14/2004 | EP0788348B1 Container with multi-phase composition for use in diagnostic and therapeutic applications |
| 07/14/2004 | CN1512881A Photosensitive and method for production thereof |
| 07/14/2004 | CN1512851A Wrinkle indicator tape strip and method of using the same |
| 07/14/2004 | CN1157185C Protein stabilized pharmacologically active agents, methods for preparation thereof and methods for use thereof |
| 07/13/2004 | US6762202 Noninvasive method for measuring vasodilation or change in blood flow following administration of a compound that donates, transfers or releases nitric oxide |
| 07/13/2004 | US6761878 Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| 07/13/2004 | US6761876 Methods for introducing helterologous cells into fish |
| 07/13/2004 | CA2202913C Antibody reagent for detecting dissecting aortic aneurysm and uses thereof |
| 07/13/2004 | CA2131528C Methods and compositions for targeting the vasculature of solid tumors |
| 07/13/2004 | CA2047699C Expanded porphyrins: large prophyrin-like tripyrroledimethine-derived macrocycles |
| 07/08/2004 | WO2004056894A1 Latex polymer particles containing fluorescent substance or contrast medium and process for producing the same |
| 07/08/2004 | WO2004056309A2 Neuroprotective activity of activated protein c is independent of its anticoagulant activity |
| 07/08/2004 | WO2004042361A3 Transgenic animals expressing light-emitting fusion proteins and diagnostic and therapeutic methods therefor |
| 07/08/2004 | WO2004038039A3 Optical imagiong of renilla luciferase reporter gene expression in living organisms |
| 07/08/2004 | WO2004037210A3 Functional mri agents for cancer imaging |
| 07/08/2004 | WO2004035022A3 Prepolymeric materials for site specific delivery to the body |
| 07/08/2004 | WO2004014301A3 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE |
| 07/08/2004 | WO2003077871A3 Method of diagnosis and treatment of breast lesions |
| 07/08/2004 | WO2003061711A8 Chromophore probes for optical imaging |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | US20040133929 Animal model for preeclampsia |
| 07/08/2004 | US20040132830 Antiproliferative agents; anticancer agents; antiinflammatory agents; autoimmune diseases |
| 07/08/2004 | US20040132124 Neuroprotection by inhibition of diacyglycerol kinase epsilon activity |